BackZevra Therapeutics Overview

Zevra Therapeutics Profit Margin

Profitability ratio analysis for KMPH.

Quarterly Profit Margin

104.61%
↑ 788.66% YoY

As of Mar 2026

Annual Profit Margin (TTM)

101.58%
↑ 127.00% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin